• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“狼疮没有掌控我,是我掌控狼疮”:运用以患者为中心的访谈来理解药物治疗不依从情况

"Lupus Doesn't Have Me, I Have Lupus": Using Patient-Centered Interviews to Understand Medication Nonadherence.

作者信息

Macko Christopher A, Santos Roger, Ramalingam Nirmala D, Tran Nicole, Zheng Sijie, Chen Patty Pei-Chang

机构信息

Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.

Kaiser Permanente East Bay Pharmacy, Oakland, CA, USA.

出版信息

Perm J. 2024 Sep 16;28(3):84-90. doi: 10.7812/TPP/23.161. Epub 2024 Jul 23.

DOI:10.7812/TPP/23.161
PMID:39042384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404647/
Abstract

BACKGROUND

Lupus nephritis (LN) is the most common cause of kidney injury in systemic lupus erythematosus and associated with higher morbidity and mortality. Low medication adherence correlates with adverse clinical outcomes.

METHODS

In a large, integrated health system at Kaiser Permanente East Bay Area, the authors identified mycophenolate mofetil (MMF) prescriptions for LN and collected patient demographics, medication adherence, and copay data. They interviewed patients with low medication adherence rates to understand contributing factors, such as side effects, cost, refill processes, and laboratory draws. Adherence was defined as a proportion of days covered at > 80%. The proportion of days covered is the number of days covered by a medication divided by the number of days in a defined period.

RESULTS

Between November 30, 2021, and November 30, 2022, the authors identified 36 patients with LN on MMF. Almost a third (11/36) of these patients were nonadherent to medication. More than half (7/11) of these patients agreed to be interviewed. They identified the following causes of medication nonadherence: forgetfulness (57%, or 4/7), incomplete laboratory work (28%, or 2/7), medication cost (14%, or 1/7), and intentionally missed doses (14%, or 1/7). No patients identified medication side effects as a cause. The median 30-day copay for MMF was $4.55, and 28% (2/7) of patients paid $0 for their medications.

CONCLUSIONS

In the authors' integrated health system, 69% of their patients with LN on MMF were adherent to their medication regimen. Forgetfulness was a challenge for the nonadherent patients. Kaiser Permanente East Bay Area provides convenient refills and laboratory draws; this likely facilitates medication adherence.

摘要

背景

狼疮性肾炎(LN)是系统性红斑狼疮中最常见的肾损伤原因,与较高的发病率和死亡率相关。药物依从性低与不良临床结局相关。

方法

在凯撒永久医疗集团东湾地区的一个大型综合医疗系统中,作者确定了狼疮性肾炎患者的霉酚酸酯(MMF)处方,并收集了患者的人口统计学数据、药物依从性和自付费用数据。他们采访了药物依从率低的患者,以了解促成因素,如副作用、费用、续方流程和实验室检查。依从性定义为覆盖天数占比>80%。覆盖天数占比是指一种药物覆盖的天数除以规定时间段内的天数。

结果

在2021年11月30日至2022年11月30日期间,作者确定了36例接受霉酚酸酯治疗的狼疮性肾炎患者。这些患者中近三分之一(11/36)未坚持服药。这些患者中有一半以上(7/11)同意接受采访。他们确定了以下药物不依从的原因:健忘(57%,即4/7)、实验室检查未完成(28%,即2/7)、药物费用(14%,即1/7)和故意漏服(14%,即1/7)。没有患者将药物副作用视为原因。霉酚酸酯的30天自付费用中位数为4.55美元,28%(2/7)的患者药物费用为0美元。

结论

在作者的综合医疗系统中,69%接受霉酚酸酯治疗的狼疮性肾炎患者坚持服药。健忘对不依从的患者来说是一个挑战。凯撒永久医疗集团东湾地区提供便捷的续方和实验室检查;这可能有助于提高药物依从性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0b/11404647/95645863ee43/tpp_23.161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0b/11404647/902244395a3e/tpp_23.161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0b/11404647/95645863ee43/tpp_23.161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0b/11404647/902244395a3e/tpp_23.161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0b/11404647/95645863ee43/tpp_23.161-g002.jpg

相似文献

1
"Lupus Doesn't Have Me, I Have Lupus": Using Patient-Centered Interviews to Understand Medication Nonadherence.“狼疮没有掌控我,是我掌控狼疮”:运用以患者为中心的访谈来理解药物治疗不依从情况
Perm J. 2024 Sep 16;28(3):84-90. doi: 10.7812/TPP/23.161. Epub 2024 Jul 23.
2
Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.他克莫司与吗替麦考酚酯在医保系统性红斑狼疮患者中的使用及预测因素分析。
Arthritis Care Res (Hoboken). 2019 Nov;71(11):1419-1424. doi: 10.1002/acr.23792.
3
Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.基于环磷酰胺和霉酚酸酯的方案治疗狼疮肾炎的长期结局。
Lupus. 2020 Jul;29(8):845-853. doi: 10.1177/0961203320926256. Epub 2020 May 21.
4
Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review.我们能否确定霉酚酸酯在系统性红斑狼疮中获益或受损的人群?一项系统评价。
Semin Arthritis Rheum. 2017 Aug;47(1):65-78. doi: 10.1016/j.semarthrit.2017.01.009. Epub 2017 Feb 9.
5
The Prevalence and Causes of Non-adherence to Immunosuppressive Medications in Patients with Lupus Nephritis Flares.狼疮性肾炎发作患者免疫抑制药物治疗依从性差的患病率及原因
Curr Rheumatol Rev. 2020;16(3):245-248. doi: 10.2174/1573397115666190626111847.
6
Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.日本对成年狼疮性肾炎患者使用吗替麦考酚酯的监测。
Mod Rheumatol. 2015;25(6):854-7. doi: 10.3109/14397595.2015.1031444. Epub 2015 Apr 30.
7
Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.霉酚酸酯或静脉注射环磷酰胺与米佐菌胺对比,用于治疗活动期狼疮性肾炎的诱导治疗。
Chin Med J (Engl). 2014;127(21):3718-23.
8
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.低剂量吗替麦考酚酯治疗系统性红斑狼疮狼疮肾炎的疗效:台湾地区病例报告。
Clin Rheumatol. 2010 Jul;29(7):771-5. doi: 10.1007/s10067-010-1403-9. Epub 2010 Mar 2.
9
Renal transplantation for lupus nephritis: non-adherence and graft survival.狼疮性肾炎的肾移植:不依从与移植物存活。
Lupus. 2019 Apr;28(5):651-657. doi: 10.1177/0961203319842641. Epub 2019 Apr 13.
10
Immunosuppressive treatment for proliferative lupus nephritis.增殖性狼疮性肾炎的免疫抑制治疗
Cochrane Database Syst Rev. 2018 Jun 29;6(6):CD002922. doi: 10.1002/14651858.CD002922.pub4.

本文引用的文献

1
Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.比较药房续药数据与化学药物依从性测试在评估安全网医院环境下药物不依从性的效果。
J Am Heart Assoc. 2022 Oct 4;11(19):e027099. doi: 10.1161/JAHA.122.027099.
2
Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data.利用药房 refill 数据进行干预以改善系统性红斑狼疮患者的用药依从性:一项先导研究。
Arthritis Care Res (Hoboken). 2023 Mar;75(3):550-558. doi: 10.1002/acr.24806. Epub 2022 Nov 11.
3
A Scoping Review of Methods Used to Assess Medication Adherence in Patients with Chronic Conditions.
对慢性病患者用药依从性评估方法的范围综述
Ann Behav Med. 2022 Nov 18;56(12):1201-1217. doi: 10.1093/abm/kaab080.
4
Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff.系统性红斑狼疮患者服药障碍的定性研究:对少数族裔患者、狼疮提供者和临床工作人员的研究。
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1459-1467. doi: 10.1002/acr.24591. Epub 2022 Jun 1.
5
Lupus nephritis: clinical presentations and outcomes in the 21st century.狼疮性肾炎:21 世纪的临床表现和结局。
Rheumatology (Oxford). 2020 Dec 5;59(Suppl5):v39-v51. doi: 10.1093/rheumatology/keaa381.
6
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis.1 年时缺乏 EULAR/ERA-EDTA 缓解预测狼疮肾炎患者的长期肾脏预后不良。
Ann Rheum Dis. 2020 Aug;79(8):1077-1083. doi: 10.1136/annrheumdis-2020-216965. Epub 2020 Jun 5.
7
Update on Lupus Nephritis: Core Curriculum 2020.狼疮肾炎更新:2020 年核心课程。
Am J Kidney Dis. 2020 Aug;76(2):265-281. doi: 10.1053/j.ajkd.2019.10.017. Epub 2020 Mar 24.
8
The Prevalence and Causes of Non-adherence to Immunosuppressive Medications in Patients with Lupus Nephritis Flares.狼疮性肾炎发作患者免疫抑制药物治疗依从性差的患病率及原因
Curr Rheumatol Rev. 2020;16(3):245-248. doi: 10.2174/1573397115666190626111847.
9
Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?羟氯喹在狼疮肾炎中的血药浓度:疾病转归的决定因素?
Nephrol Dial Transplant. 2018 Sep 1;33(9):1604-1610. doi: 10.1093/ndt/gfx318.
10
Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis.系统性红斑狼疮中抑郁和焦虑的患病率:一项系统评价和荟萃分析。
BMC Psychiatry. 2017 Feb 14;17(1):70. doi: 10.1186/s12888-017-1234-1.